GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (FRA:ET8) » Definitions » Pre-Tax Income

Cosciens Biopharma (FRA:ET8) Pre-Tax Income : €-10.55 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cosciens Biopharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cosciens Biopharma's pretax income for the three months ended in Sep. 2024 was €-5.29 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was €-10.55 Mil. Cosciens Biopharma's pretax margin was -313.52%.

During the past 13 years, Cosciens Biopharma's highest Pretax Margin was 39.22%. The lowest was -152.22%. And the median was 15.11%.


Cosciens Biopharma Pre-Tax Income Historical Data

The historical data trend for Cosciens Biopharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Pre-Tax Income Chart

Cosciens Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.78 1.20 2.29 4.02 -4.08

Cosciens Biopharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 -1.84 -1.67 -1.76 -5.29

Competitive Comparison of Cosciens Biopharma's Pre-Tax Income

For the Biotechnology subindustry, Cosciens Biopharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosciens Biopharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cosciens Biopharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cosciens Biopharma's Pre-Tax Income falls into.



Cosciens Biopharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cosciens Biopharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.324+0.068+-0.089+0.302+-0.038999999999999
=-4.08

Cosciens Biopharma's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.355+-0.911+-0.02+0+0
=-5.29

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosciens Biopharma  (FRA:ET8) Pre-Tax Income Explanation

Cosciens Biopharma's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-5.286/1.686
=-313.52%

During the past 13 years, Cosciens Biopharma's highest Pretax Margin was 39.22%. The lowest was -152.22%. And the median was 15.11%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosciens Biopharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cosciens Biopharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosciens Biopharma Business Description

Traded in Other Exchanges
Address
c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, Toronto, ON, CAN, M5K 1E7
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.

Cosciens Biopharma Headlines

No Headlines